4BI1
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-04-13 |
Detector | MARMOSAIC 225 mm CCD |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 70.910, 111.820, 113.570 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 56.780 - 2.700 |
R-factor | 0.1896 |
Rwork | 0.188 |
R-free | 0.22830 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2zmc |
RMSD bond length | 0.010 |
RMSD bond angle | 1.200 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 56.780 | 2.850 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.070 | 0.520 |
Number of reflections | 12760 | |
<I/σ(I)> | 10.6 | 2.4 |
Completeness [%] | 100.0 | 100 |
Redundancy | 4 | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 291 | 30-45% (V/V) PEG300, SITTING DROP VAPOUR DIFFUSION, 291K, pH 7.5 |